期刊文献+

基因敲除模型与药物作用新靶点的发现 被引量:5

Gene Knockout Model and New Drug Target Discovery
下载PDF
导出
摘要 基因敲除技术是近年来发展起来的一种新兴的技术。它运用分子生物学的手段去除某一特定的基因制成基因敲除动物模型 ,通过这一模型来探究疾病的发病机制和病理特征 ,为疾病的预防、诊断和治疗提供依据。这一技术被成功地用于药物作用新靶点的发现 ,为疾病的治疗提供全新的机制。本文回顾了近年来基因敲除技术的最新研究进展 ,指出基因敲除技术将对创新药物的发现产生极大的促进作用 ,具有巨大的潜力 。 Gene knockout is a newly developed tec hnique in recent years The gene knockout model is developed by knockout specific gene using molecular biology m ethod The model has been successfully used to investigate the pathogenesis an d pathological characteristics of diseases which will provide a scientific basi s for prevention,diagnosis and treatment of diseases The tec hnique has been also successfully applied to the finding of new target for drugs which will provide novel mechanism for the therapy of diseases The paper revi ews t he recent advances in gene knockout technique and its application in the findin g of new targets for drugs. It also stress that the application of t his techniq ue in new drug development will bring about a great advance in new drug develo pment and may achieve breakthrough in alternative ways for treatment of some diseases
出处 《中国药科大学学报》 CAS CSCD 北大核心 2004年第1期1-6,共6页 Journal of China Pharmaceutical University
基金 国家自然科学基金(编号 :39970 86 2 ) 国家 973基金 (编号 :1 9980 51 1 1 9) 国家 86 3计划 (编号 :2 0 0 3AA2Z34 7A) 江苏省药物代谢动力学重点实验室资助项目(编号 :BM2 0 0 1 2 0 1 )~~
关键词 基因 敲除 药物 靶点 研发 Gene Knockout Target R&D
  • 相关文献

参考文献31

  • 1[1]Hopkins AL,Groom CR.The druggable genome [ J ].Nature RevDrug Discov,2002,1:723-730.
  • 2[2]Scappini B.Onida F,Kantarjian HM,et al.In vitro effect of STI571-containing drug combinations on the growth of philadelphiapositive chronic myelogenous leukemia cells[ J ].Cancer,2002,94:2653-2662.
  • 3[3]Scarff KL,Judd LM,Toh BH,et al.Gastric H+ ,K+ -adenosine triphosphatase β subunit is required for normal function,development,and membrane structure of mouse parietal cells [ J ] .Gastroenterology,1999,117:605-668.
  • 4[4]Lieschke GJ,Grail D,Hodgson G,et al.Mice lacking granulocyte colonystimulating factor have chronic neutropenia,granulocyte and macrophage progenitor cell deficiency,and impaired neutrophil mobilization[J].Blood ,2000,84:1737-1746.
  • 5[5]Langenbach R,Morham SG,Tiano HF,et al.Prostaaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration[ J ].Cell,1995,83:483-492.
  • 6[6]Mroteau O,Morham SG,Sellon R,et al.Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2 [ J].J Clin Invest,2000,105:469-478.
  • 7[7]Ballou LR,Botting RM,Goorha S,et al.Nociception in cyclooxygenase isozyme-deficient mice[J].Proc Natl Acad Sci USA,2000,97:10272-10276.
  • 8[8]Chulada PC,Thompson MB,Mahler JF,et al.Genetic disruption of Ptgs-1,as well as Ptgs-2,reduces intestinal tumorigenesis in mice[ J ] .Cancer Res,2000,60(17),4705-4708.
  • 9[9]Tiano HF,Loftin CD,Akunda J,et al.Deficiency of either cyclooxygenase(COX)-1 or(COX)-2 alters epidermal diffrentiation and reduces mouse skin tumorigenesis [ J ] .Cancer Res,2002,62(12):3395-401.
  • 10[10]Morham SG,Langenbach R,Loftin CD,et al.Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse [ J ].Cell,1995,83:473-482.

同被引文献65

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部